Anserine inhibits carnosine degradation but in human serum carnosinase (CN1) is not correlated with histidine dipeptide concentration - PubMed (original) (raw)

. 2011 Jan 30;412(3-4):263-7.

doi: 10.1016/j.cca.2010.10.016. Epub 2010 Oct 21.

Erwin E W Jansen, Cornelis Jakobs, Eva Riedl, Bart Janssen, Benito A Yard, Johannes Wedel, Georg F Hoffmann, Johannes Zschocke, Daniel Gotthardt, Christine Fischer, Hannes Köppel

Affiliations

• PMID: 20971102
• DOI: 10.1016/j.cca.2010.10.016

Anserine inhibits carnosine degradation but in human serum carnosinase (CN1) is not correlated with histidine dipeptide concentration

Verena Peters et al. Clin Chim Acta. 2011.

Abstract

Background: We reported an association of a particular allele of the carnosinase (CNDP1 Mannheim) gene with reduced serum carnosinase (CN1) activity and absence of nephropathy in diabetic patients. Carnosine protects against the adverse effects of high glucose levels but serum carnosine concentration was generally low.

Methods: We measured the concentration of two further histidine dipeptides, anserine and homocarnosine, via HPLC. CN1 activity was measured fluorometically and for concentration we developed a capture ELISA.

Results: We found an association between the CNDP1 Mannheim allele and reduced serum CN1 activity for all three dipeptides but no correlation to serum concentrations although anserine and homocarnosine inhibited carnosinase activity. Patients with liver cirrhosis have low CN1 activity (0.24 ± 0.17 μmol/ml/h, n=7 males; normal range: 3.2 ± 1.1, n=104; p<0.05) and CN1 concentrations (2.3 ± 1.5 μg/ml; normal range: 24.9 ± 8.9, p<0.05) but surprisingly, histidine dipeptide concentrations in serum are not increased compared to controls.

Conclusions: Serum histidine dipeptide concentrations are not correlated to CN1 activity. The protective effect of low CN1 activity might be related either to turnover of CN1 substrates or a protective function of dipeptides might be localized in other tissues.

Copyright © 2010 Elsevier B.V. All rights reserved.

PubMed Disclaimer

Similar articles

• A Global Cndp1-Knock-Out Selectively Increases Renal Carnosine and Anserine Concentrations in an Age- and Gender-Specific Manner in Mice.
  Weigand T, Colbatzky F, Pfeffer T, Garbade SF, Klingbeil K, Colbatzky F, Becker M, Zemva J, Bulkescher R, Schürfeld R, Thiel C, Volk N, Reuss D, Hoffmann GF, Freichel M, Hecker M, Poth T, Fleming T, Poschet G, Schmitt CP, Peters V. Weigand T, et al. Int J Mol Sci. 2020 Jul 10;21(14):4887. doi: 10.3390/ijms21144887. Int J Mol Sci. 2020. PMID: 32664451 Free PMC article.
• Carnosine treatment largely prevents alterations of renal carnosine metabolism in diabetic mice.
  Peters V, Schmitt CP, Zschocke J, Gross ML, Brismar K, Forsberg E. Peters V, et al. Amino Acids. 2012 Jun;42(6):2411-6. doi: 10.1007/s00726-011-1046-4. Epub 2011 Aug 11. Amino Acids. 2012. PMID: 21833769
• Intrinsic carnosine metabolism in the human kidney.
  Peters V, Klessens CQ, Baelde HJ, Singler B, Veraar KA, Zutinic A, Drozak J, Zschocke J, Schmitt CP, de Heer E. Peters V, et al. Amino Acids. 2015 Dec;47(12):2541-50. doi: 10.1007/s00726-015-2045-7. Epub 2015 Jul 24. Amino Acids. 2015. PMID: 26206726 Free PMC article.
• Carnosinase, diabetes mellitus and the potential relevance of carnosinase deficiency.
  Peters V, Zschocke J, Schmitt CP. Peters V, et al. J Inherit Metab Dis. 2018 Jan;41(1):39-47. doi: 10.1007/s10545-017-0099-2. Epub 2017 Oct 13. J Inherit Metab Dis. 2018. PMID: 29027595 Review.
• [Carnosine, carnosinase and kidney diseases].
  Kiliś-Pstrusińska K. Kiliś-Pstrusińska K. Postepy Hig Med Dosw (Online). 2012 Apr 20;66:215-21. doi: 10.5604/17322693.991600. Postepy Hig Med Dosw (Online). 2012. PMID: 22706107 Review. Polish.

Cited by

• Carnosine treatment for gulf war illness: a randomized controlled trial.
  Baraniuk JN, El-Amin S, Corey R, Rayhan R, Timbol C. Baraniuk JN, et al. Glob J Health Sci. 2013 Feb 4;5(3):69-81. doi: 10.5539/gjhs.v5n3p69. Glob J Health Sci. 2013. PMID: 23618477 Free PMC article. Clinical Trial.
• Anserine, a Histidine-Containing Dipeptide, Suppresses Pressure Overload-Induced Systolic Dysfunction by Inhibiting Histone Acetyltransferase Activity of p300 in Mice.
  Sunagawa Y, Tsukabe R, Irokawa Y, Funamoto M, Suzuki Y, Yamada M, Shimizu S, Katanasaka Y, Hamabe-Horiike T, Kawase Y, Naruta R, Shimizu K, Mori K, Hosomi R, Komiyama M, Hasegawa K, Morimoto T. Sunagawa Y, et al. Int J Mol Sci. 2024 Feb 16;25(4):2344. doi: 10.3390/ijms25042344. Int J Mol Sci. 2024. PMID: 38397020 Free PMC article.
• Carnosinases, their substrates and diseases.
  Bellia F, Vecchio G, Rizzarelli E. Bellia F, et al. Molecules. 2014 Feb 21;19(2):2299-329. doi: 10.3390/molecules19022299. Molecules. 2014. PMID: 24566305 Free PMC article. Review.
• Metabolomic profiling of amino acids study reveals a distinct diagnostic model for diabetic kidney disease.
  Wang J, Zhou C, Zhang Q, Liu Z. Wang J, et al. Amino Acids. 2023 Nov;55(11):1563-1572. doi: 10.1007/s00726-023-03330-0. Epub 2023 Sep 22. Amino Acids. 2023. PMID: 37736814 Free PMC article.
• Protective Actions of Anserine Under Diabetic Conditions.
  Peters V, Calabrese V, Forsberg E, Volk N, Fleming T, Baelde H, Weigand T, Thiel C, Trovato A, Scuto M, Modafferi S, Schmitt CP. Peters V, et al. Int J Mol Sci. 2018 Sep 13;19(9):2751. doi: 10.3390/ijms19092751. Int J Mol Sci. 2018. PMID: 30217069 Free PMC article.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Elsevier Science

• Other Literature Sources

  • The Lens - Patent Citations Database

• Miscellaneous

  • NCI CPTAC Assay Portal